Dr. Jackson is an assistant professor in the Division of Infectious Diseases and International Health at the University of Virginia. He received his MD from UVA, and remained there for his residency in internal medicine and fellowship in infectious diseases. His clinical practice focuses on HIV medicine and general infectious diseases. He studies HIV virology in the Myles H. Thaler Center for AIDS and Human Retrovirus Research. Since the beginning of the COVID-19 pandemic, he has helped to coordinate the use of COVID-19 therapeutics at UVA and he is the site principal investigator for the Adaptive COVID-19 Treatment Trial.

Dr. Andrew Whitman is a clinical pharmacist in oncology and palliative care at the University of Virginia Health System in Charlottesville, VA. He completed a combined Doctor of Pharmacy degree and Certificate of Aging Studies at Virginia Commonwealth University School of Pharmacy. Dr. Whitman completed his postgraduate training at the University of Virginia Health System in oncology pharmacy followed by a year as a palliative care specialist at the University of Maryland Baltimore Washington Medical Center. His main research interests include deprescribing in older cancer patients and innovative approaches to supportive care.